Kolageninis, MB - financials and debts

Company age: 4 y. 5 mo.

Update

Kolageninis - Company finances

EUR
2022
From: 2022-04-19
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 6,043 15,832 34,489 68,250
Profit before tax -3,036 -8,510 7,085 5,549
Net profit -3,036 -8,510 7,085 5,484
Equity -2,036 -10,545 -3,460 2,024
Liabilities 4,072 22,570 15,756 50,180
Non-current assets 113 6,695 4,706 4,644
Current assets 1,923 5,330 7,590 47,560
Total assets 2,036 12,025 12,296 52,204
Taxes paid
STI taxes - 98 3 5,976
Financial indicators
Revenue change y/y - +162.0% +117.8% +97.9%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -149.1% -70.8% 57.6% 10.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - 270.9%
Profit margin Net profit margin. Shows the overall profitability of the company. -50.2% -53.8% 20.5% 8.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -50.2% -53.8% 20.5% 8.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - 24.8
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Kolageninis - Social security debts

From To Debt, €
2023-04-03 2023-04-30 58.63

Kolageninis - VMI tax arrears

From To Overdue, €
2026-08-02 2026-08-29 6.72
2026-06-30 2026-07-26 0.08
2025-06-24 2025-06-24 0.0
2025-06-23 2025-06-23 0.0
2025-06-22 2025-06-22 0.0
2025-06-20 2025-06-21 0.0
2025-06-19 2025-06-19 0.0
2025-06-18 2025-06-18 0.0
2025-06-17 2025-06-17 0.0
2025-06-16 2025-06-16 0.0
2025-06-15 2025-06-15 0.0
2025-06-14 2025-06-14 0.0
2025-06-12 2025-06-13 0.0
2025-06-11 2025-06-11 0.0
2025-06-10 2025-06-10 0.0
2025-06-06 2025-06-09 0.0
2025-06-05 2025-06-05 0.0
2025-06-04 2025-06-04 0.0
2025-06-02 2025-06-03 0.0
2025-06-01 2025-06-01 0.0
2025-05-30 2025-05-31 0.0
2025-05-29 2025-05-29 0.0
2025-05-28 2025-05-28 0.0
2025-05-24 2025-05-27 0.0
2025-05-20 2025-05-23 0.0
2025-05-19 2025-05-19 0.0
2025-05-17 2025-05-18 0.0
2025-05-13 2025-05-16 0.0
2025-05-12 2025-05-12 0.0
2025-05-08 2025-05-11 0.0
2025-05-07 2025-05-07 0.0
2025-05-06 2025-05-06 0.0
2025-05-05 2025-05-05 0.0
2025-05-03 2025-05-04 0.0
2025-05-01 2025-05-02 0.0
2025-04-30 2025-04-30 0.0
2025-04-28 2025-04-29 0.0
2025-04-27 2025-04-27 0.0
2025-04-25 2025-04-26 0.0
2025-04-24 2025-04-24 0.0
2025-04-22 2025-04-23 0.0
2025-04-20 2025-04-21 0.0
2025-04-18 2025-04-19 0.0
2025-04-17 2025-04-17 0.0
2025-04-16 2025-04-16 0.0
2025-04-14 2025-04-15 0.0
2025-04-11 2025-04-13 0.0
2025-04-10 2025-04-10 0.0
2025-04-09 2025-04-09 0.0
2025-04-08 2025-04-08 0.0
2025-04-07 2025-04-07 0.0
2025-04-06 2025-04-06 0.0
2025-04-04 2025-04-05 0.0
2025-04-03 2025-04-03 0.0
2025-04-02 2025-04-02 0.0
2025-03-31 2025-04-01 0.0
2025-03-30 2025-03-30 0.0
2025-03-27 2025-03-29 0.0
2025-03-26 2025-03-26 0.0
2025-03-24 2025-03-25 0.0
2025-03-22 2025-03-23 0.0
2025-03-20 2025-03-21 0.0
2025-03-19 2025-03-19 0.0
2025-03-17 2025-03-18 0.0
2025-03-16 2025-03-16 0.0
2025-03-15 2025-03-15 0.0
2025-03-12 2025-03-14 0.0
2025-03-11 2025-03-11 0.0
2025-03-10 2025-03-10 0.0
2025-03-09 2025-03-09 0.0
2025-03-07 2025-03-08 0.0
2025-03-06 2025-03-06 0.0
2025-03-05 2025-03-05 0.0
2025-03-04 2025-03-04 0.0
2025-02-28 2025-03-03 1506.0
2025-02-02 2025-02-07 0.44
2025-01-30 2025-01-31 419.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Kolageninis, MB (code 306066152) is a Small partnership engaged in the manufacture of homogenised food preparations and dietetic food. In 2025, the company generated €68.2K in revenue, up from €34.5K in 2024 and €15.8K in 2023, showing a strong three-year expansion. Net profit in 2025 was €5.5K, compared with €7.1K in 2024 after a loss of €8.5K in 2023, indicating a move from loss-making operations to profitability, although margins have narrowed from 20.5% in 2024 to 8.0% in 2025 as sales scaled up. Balance sheet strength improved, with equity turning positive at €2.0K in 2025 after negative equity in 2023 and 2024. Total assets increased to €52.2K, supported mainly by short-term assets of €47.6K, while long-term assets were €4.6K. Liabilities rose to €50.2K, leaving the balance sheet still highly leveraged and equity thin. In 2025, return on assets was 10.5% and asset turnover reached 1.31x, while return on equity was exceptionally high because equity remained very small.